Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Teladoc (TDOC) declined 3.64% in the latest trading session, significantly underperforming the broader market. The stock has depreciated 7.83% over the past month, underperforming the Medical sector. Upcoming earnings are projected to show a loss of $0.23 per share with revenue declining 6.53% year-over-year. The company holds a Zacks Rank of #3 (Hold) with unchanged consensus EPS estimates over the last 30 days.